|
|
![]() |
|
|
|
|
|
|
|
|
|
|
![]() |
|
||||||||||
|
|
|
||||||||||
|
|
|
||||||||||
|
|
||||||||||
“Changes in Atrial Natriuretic Factor (ANF) and Ca+2 ATPase mRNA transcriptional activity are markers of myocardial integrity during continuous warm blood cardioplegia (CWBCP) in rats.” Remsey ES, Baig M, Kral JG, Kavesteen Eghbali D, Varga M, Wait RB, Siddiqui MA. Annals of the New York Academy of Sciences. 793:419-22, 1996 Sep 30. 97062445 “The Potential Impact of a Fully Automated External Cardioverter-Defibrillator in Centrally Monitored Hospital Units. "Jacob Shani, Gerald Hollander, David Kavesteen, Henery Cusnir, Rohit Tongia. 52nd Annual Scientific session of American College of Cardiology March 30 –April 2, 2003 Chicago. “Effect of continuous warm blood cardioplegia and reperfusion on the transcriptional activity of Creatine Kinase mRNA in rat’s myocardium.” Remsey E. S, Anderson J. E, Kavesteen E. D, Brunner R. E, Cunningham J. N, Wait R. B. 28th Annual Scientific Symposium of the Hungarian Medical Association of America; Oct 27-Nov 1, 1996, Sarasota, Florida. |
|
||||||||||
|
|
|
||||||||||
|
|
|
||||||||||
Youth Employment Award City Hall Mayor David Dinkins |
|
||||||||||
David Kavesteen, MD is a graduate of Medicine from SUNY Health Science Center. He completed his residency at the prestigious New York University Medical Center and continued further education in Maimonides Medical Center specializing in cardiology and cardiovascular diseases. |
|
||||||||||
|
|
|
|
|||||||||
Anticoagulation effect of Warfarin in preventing embolization in patients with atherosclerotic disease of thoracic aorta base on transesophageal echocardiography.
Effect of continuous warm blood cardioplegia and reperfusion on the transcriptional activity of Creatine Kinase, ANF, Ca ATP-ase, Heat Shock Protein 70 mRNA in myocardium of rat. SUNY Health Science Center at Brooklyn |
|
|
|||||||||
|
|
|
||||||||||
|
|
Home |
Procedures |
Symptoms | Clinics | Insurance Heart and Health | Healtheon Medical Services | Contact Us | Feedback |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|